title: [Efficacy of reflexology in the combination with neuroprotective treatment in hemiparetic form of children cerebral palsy].
abstract: Sixty patients with the diagnosis of cerebral palsy with hemiparesis at the age from 2 to 7 years were treated. All 60 patients had conventional treatment including massage and exercise therapy. Patients were divided into 2 randomized groups. The patients of the first group were given 3 sets of microcurrent reflexology sessions and 2 courses of treatment with cortexin. Patients of the second group were given reflexology treatments only. The microcurrent reflexology treatment included 15 sessions using the apparatus MAKS. Cortexin was introduced intramuscularly in dosage 10 mg. The bottle content was diluted in 2 ml of 0.5% novocaine. The treatment included 10 injections. This treatment showed the beneficial effects: 29 patients of the first group (97%) and 27 patients of the second group (90%) developed some ambulation skills. The progress in complicated manipulative activity of paralyzed upper extremities under microcurrent reflexology with cortexin was 2.2 times more visible in patients of the first group compared to the second one (11 patients (37%) versus 5 patients (17%), respectively). Positive changes in the encephalon functional status according to electroencephalography results were found in 21 patients (71%) of the first group and in 16 patients (53%) of the second group.
authors.forename: T A
authors.initials: TA
authors.lastname: Ukhanova
authors.forename: F E
authors.initials: FE
authors.lastname: Gorbunov
mesh_terms: D002547:Cerebral Palsy / Q000188:drug therapy / Q000534:rehabilitation*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005081:Exercise Therapy; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins; D008297:Male; D008405:Massage; D010291:Paresis / Q000188:drug therapy / Q000534:rehabilitation*; D010455:Peptides / Q000008:administration & dosage / Q000627:therapeutic use*; D012028:Reflexotherapy / Q000295:instrumentation / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; C056590:cortexin